Gastroesophageal reflux disease increases predisposition to severe COVID‐19: Insights from integrated Mendelian randomization and genetic analysis

Jingjing Pan,Jianhua Li
DOI: https://doi.org/10.1111/ahg.12584
2024-11-16
Annals of Human Genetics
Abstract:Objective This study aims to investigate the potential causal relationship, shared genomic loci, as well as potential molecular pathways and tissue‐specific expression patterns between gastroesophageal reflux disease (GERD) and the risk of hospitalized/severe 2019 coronavirus disease (COVID‐19). Methods We employed linkage disequilibrium score regression and bidirectional Mendelian randomization (MR) analysis to explore potential genetic associations between GERD (N = 602,604) and hospitalized COVID‐19 (N = 2095,324) as well as severe COVID‐19 (N = 1086,211). Additionally, shared genomic loci were extracted from common pivotal regions, further confirmed through corresponding colocalization analyses. GERD‐driven molecular pathway network was constructed using extensive literature data mining to understand the molecular‐level impacts of GERD on COVID‐19. Results Our results revealed a significant positive genetic correlation between GERD and both hospitalized (rg = 0.418) and severe COVID‐19 (rg = 0.314). Furthermore, the MR analysis demonstrated a unidirectional causal effect of genetic predisposition to GERD on COVID‐19 outcomes, including hospitalized COVID‐19 (odds ratio [OR]: 1.33, 95% confidence interval [CI]: 1.27–1.44, p = 9.17e − 12) and severe COVID‐19 (OR: 1.27, 95% CI: 1.18–1.37, p = 1.20e − 05). Additionally, GERD and both COVID‐19 conditions shared one genomic locus with lead‐SNPs rs1011407 and rs1123573, corresponding to the transcription factor BCL11A. Colocalization analysis further demonstrated a significant positive correlation between genome‐wide association study and expression quantitative trait locus (eQTL) abnormalities, including rs1011407 (eQTL_p = 2.35e − 07) and rs1123573 (eQTL_p = 2.74e − 05). Molecular pathway analysis indicated that GERD might promote the progression of COVID‐19 by inducting immune‐activated and inflammation‐related pathways. Conclusion These findings confirm that genetically determined GERD may increase the susceptibility to hospitalized/severe COVID‐19. The shared genetic loci and the potential molecular pathways offer valuable insights into causal connections between GERD and COVID‐19.
genetics & heredity
What problem does this paper attempt to address?